13 results
10-12G/A
NSTM
NovelStem International Corp.
28 Jun 23
Registration of securities (amended)
2:46pm
in July 2018, Mr. Loeb has acted in an executive capacity on behalf of the Company and has served in a de facto leadership role. In September 2022 … of our common stock could be materially adversely affected. Leadership changes will occur from time to time and we cannot predict whether significant
10-12G/A
NSTM
NovelStem International Corp.
6 Dec 22
Registration of securities (amended)
5:52pm
adversely affected. Leadership changes will occur from time to time and we cannot predict whether significant resignations will occur or whether NewStem … is a life science executive with significant leadership, operational and strategic experience from over 25 years in the field. He is currently
10-12G/A
NSTM
NovelStem International Corp.
13 Oct 22
Registration of securities (amended)
11:17am
of revenue, and the value of our common stock could be materially adversely affected. Leadership changes will occur from time to time and we cannot predict … . Richman is a life science executive with significant leadership, operational and strategic experience from over 25 years in the field. He is currently
10-12G
h6qc61bk33g54h57og1
2 Aug 22
Registration of securities
12:31pm
8-K
EX-99.1
lmsbifqecp1y9
28 Aug 06
The New York Times Company Acquires
12:00am
8-K
EX-99.1
rqfgd7 w4b8
24 Mar 05
Hollywood Media Corp. Reports 2004 Financial Results
12:00am
- Prev
- 1
- Next